Skip to main content

Table 4 Stratified analysis for the associations between blood Cd and prognostic outcomes

From: Association of blood cadmium concentration with chronic obstructive pulmonary disease progression: a prospective cohort study

Stratification characteristic

Acute exacerbation

Hospitalization

Hospital stays

Death

Age (years)

    

  ≤ 74.0

0.136 (0.013, 1.419)

0.358 (0.065, 1.981)

1.745 (0.366, 8.318)

5.873 (0.529, 65.172)

  > 74.0

0.659 (0.058, 7.437)

0.013 (0.002, 73.445)

1.327 (1.129, 9.819)

5.502 (1.169, 25.900)

 Pinteraction

0.365

0.254

0.032

0.045

Sex

    

 Male

0.307 (0.067, 1.410)

0.324 (0.079, 1.339)

1.748 (1.024, 5.829)

3.358 (1.139, 9.903)

 Female

1.201 (0.325, 2.541)

0.651 (0.205, 1.587)

1.225 (1.005, 4.638)

2.025 (0.895, 5.625)

 Pinteraction

0.958

0.356

0.236

0.524

Smoking amount (n)

    

  ≤ 40.0

4.513 (0.408, 49.919)

0.918 (0.123, 6.832)

1.809 (1.209, 15.670)

9.811 (1.317, 73.0587)

  > 40.0

2.603 (0.306, 22.167)

1.112 (0.658, 2.541)

0.105 (0.003, 3.188)

6.966 (1.711, 68.224)

 Pinteraction

0.524

0.098

0.086

0.044

Hypertension

    

Yes

1.052 (0.652, 2.365)

1.849 (0.002, 5.628)

5.431 (0.265, 7.958)

3.360 (0.001, 8.954)

No

20.238 (0.333, 128.880)

13.737 (0.423, 446.354)

0.394 (0.043, 3.632)

5.119 (1.831, 31.526)

Pinteraction

0.632

0.452

0.254

0.254

Diabetes mellitus

    

 Yes

2.677 (0.652, 4.857)

1.125 (0.658, 4.852)

1.115 (0.777, 5.834)

2.855 (1.125, 9.562)

 No

2.555 (0.404, 16.172)

1.438 (0.262, 7.9801)

1.459 (1.289, 6.396)

3.660 (1.440, 15.953)

 Pinteraction

0.325

0.258

0.043

0.036

Coronary disease

    

 Yes

8.315 (0.652, 13.658)

1.258 (0.687, 2.641)

1.362 (1.112, 3.658)

1.121 (0.958, 3.521)

 No

3.260 (0.433, 24.531)

1.438 (0.923, 1.240)

0.736 (0.156, 3.461)

3.691 (1.169, 15.679)

 Pinteraction

0.154

0.325

0.365

0.859

Cerebrovascular diseases

    

 Yes

1.251 (0.658, 7.958)

0.658 (0.112, 4.658)

1.285 (1.058, 5.628)

1.652 (1.115, 4.987)

 No

2.911 (0.443, 19.111)

0.696 (0.127, 3.823)

1.359 (1.009, 6.396)

3.710 (1.070, 15.823)

 Pinteraction

0.332

0.215

0.032

0.045

FVC (L)

    

  ≤ 2.15

0.999 (0.733, 2.156)

0.976 (0.265, 1.854)

0.958 (0.365, 1.254)

2.067 (1.300, 4.652)

  > 2.15

3.627 (0.587, 6.528)

0.989 (0.528, 1.547)

1.654 (0.687, 2.154)

1.339 (0.091, 29.265)

 Pinteraction

0.069

0.215

0.063

0.036

FEV1 (L)

    

  ≤ 1.83

1.254 (0.658, 2.654)

1.125 (0.658, 1.587)

3.025 (1.115, 7.895)

2.635 (1.325, 7.854)

  > 1.83

0.969 (0.658, 2.152)

1.108 (0.778, 2.591)

2.625 (0.879, 3.654)

1.895 (1.112, 4.628)

 Pinteraction

0.138

0.652

0.025

0.030

FEV1/FVC (%)

    

  ≤ 62.45

1.125 (0.857, 3.254)

1.168 (0.789, 2.635)

1.652 (0.658, 4.658)

2.025 (1.116, 4.258)

  > 62.45

1.254 (0.758, 2.654)

1.658 (0.857, 3.658)

1.115 (0.878, 3.652)

1.365 (0.879, 3.624)

 Pinteraction

0.328

0.125

0.205

0.326

Predicted FEV1 (%)

    

  ≤ 54.05

1.259 (0.638, 1.698)

1.326 (0.832, 2.365)

0.788 (0.451, 8.152)

2.630 (0.154, 10.385)

  > 54.05

0.994 (0.411, 2.365)

1.111 (0.658, 2.635)

2.081 (0.658, 2.635)

1.366 (0.879, 2.920)

 Pinteraction

0.268

0.360

0.428

0.365

  1. Models were adjusted for age, gender, smoking amount, comorbidities, inhaled therapy for COPD, and pulmonary function indices. Bold values indicate statistical significance